Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 2176 AL 2190

Epigenetic biomarkers in neurodegenerative diseases: from molecular signatures to therapeutic targets

Washer SJ, Frith M, Cowan E, Dempster E, Mill J, Farrow SL.

Trends Neurosci. 2026 May;49(5):373-389. doi: 10.1016/j.tins.2026.03.004. Epub 2026 Apr 16.

Golgi-associated membrane scaffolds: roles in health and disease

Speckmann T, Saurenbach J, Schürmann A.

Biol Chem. 2026 May 26. doi: 10.1515/hsz-2025-0242. Online ahead of print.

Recent Advances in Erinacine A: Preparation, Biological Activities, and Biosynthetic Pathway

Wang J, Liu H, Wang C, Liu C.

Molecules. 2026 Jan 8;31(2):219. doi: 10.3390/molecules31020219.

DJ-1 (PARK7) as a Redox-Responsive Integrator of Pancreatic, Hepatic, and Adipose Crosstalk in Glucose Homeostasis

Jayasingha JMPS, Madushan MAH, Jayathilaka NS, Sabarathinam S.

Compr Physiol. 2026 Apr;16(2):e70123. doi: 10.1002/cph4.70123.

Quantitative ophthalmic posterior segment optical coherence tomography angiography and neurologic conditions: a review

Drakopoulos M, Lyons CE, Sikora H, Abbott S, Volpe N, Mirza RG.

Front Neurol. 2026 Jan 23;17:1746695. doi: 10.3389/fneur.2026.1746695. eCollection 2026.

HMGB1-mediated neuroinflammation: molecular mechanisms and emerging therapeutic approaches

Ibrahim KN, Wasim R, Rahman E.

Inflammopharmacology. 2026 May;34(5):3085-3108. doi: 10.1007/s10787-026-02211-8. Epub 2026 Apr 11.

Urinary Biomarkers in Parkinson's Disease: A Structured Integrative Review of Pathophysiological Pathways

Santos HQP, Sumita NM, Alberto-Silva C, Echeverry MB.

Med Sci (Basel). 2026 May 17;14(2):258. doi: 10.3390/medsci14020258.

Smart assistive technologies for neurodisorders: A review on AI, IoT, and wearable systems for enhanced patient care

Chouhan S, Ghai D, Sandhu R, Tripathi SL.

Neurol Sci. 2026 Jan 30;47(2):211. doi: 10.1007/s10072-025-08790-8.

Double-edged role of N6-methyladenosine reader YTH structural domain family protein 2 in neurological disorders: Molecular mechanisms and translational prospects

Liu YM, Liu M, Yuan H, Li B.

World J Exp Med. 2026 Mar 20;16(1):116383. doi: 10.5493/wjem.v16.i1.116383. eCollection 2026 Mar 20.

Metabotropic Glutamate Receptor-Dependent Synaptic Plasticity in Age-Related Neurodegenerative Disorders

Basha S, Vijeev A, Nadig SS, Agarwal K, Meharchandani V, Pai AR, Mahato KK.

Neural Plast. 2026;2026(1):e3455379. doi: 10.1155/np/3455379.

α-Synuclein as a molecular link between Parkinson's disease and chronic kidney disease: insights into the kidney-brain axis

Kumari S, Goutam N, Chaudhary V, Rana S, Kushawaha SK, Sharma A, Ashawat MS, Joshi G, Joshi N.

Metab Brain Dis. 2026 May 19;41(1):106. doi: 10.1007/s11011-026-01864-2.

Reversible Parkinsonism With Recovery of 123 I-Ioflupane DAT‑SPECT After Treating Rheumatoid Meningitis

Bannai T, Yoshii K, Yamada M, Seki T, Shiio Y.

Clin Nucl Med. 2026 Apr 1;51(4):349-350. doi: 10.1097/RLU.0000000000006361. Epub 2026 Feb 4.

Differentiating neurologic disorders from spinal conditions: evidenced-based history and physical examination clues for the orthopedic clinic

Nassar JE, Knebel A, Ammar LA, Singh M, Kuris EO, Diebo BG, Daniels AH.

Am J Med. 2026 Apr 18:S0002-9343(26)00284-6. doi: 10.1016/j.amjmed.2026.04.017. Online ahead of print.

[The effectiveness of citicoline in the treatment of cognitive disorders]

Shavlovskaya OA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(3):136-140. doi: 10.17116/jnevro2026126031136.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias